Zobrazeno 1 - 10 of 61 pro vyhledávání: '"Canan, Alhan"'
2
Multiparameter flow cytometry in the evaluation of myelodysplasia
Autor: Anna Porwit, Marie C. Béné, Carolien Duetz, Sergio Matarraz, Uta Oelschlaegel, Theresia M. Westers, Orianne Wagner‐Ballon, Shahram Kordasti, Peter Valent, Frank Preijers, Canan Alhan, Frauke Bellos, Peter Bettelheim, Kate Burbury, Nicolas Chapuis, Eline Cremers, Matteo G. Della Porta, Alan Dunlop, Lisa Eidenschink‐Brodersen, Patricia Font, Michaela Fontenay, Willemijn Hobo, Robin Ireland, Ulrika Johansson, Michael R. Loken, Kiyoyuki Ogata, Alberto Orfao, Katherina Psarra, Leonie Saft, Dolores Subira, Jeroen te Marvelde, Denise A. Wells, Vincent H. J. van der Velden, Wolfgang Kern, Arjan A. van de Loosdrecht
Publikováno v: Cytometry. Part B-Clinical Cytometry, 104, 1, pp. 27-50
Cytometry. Part B-Clinical Cytometry, 104, 27-50
Porwit, A, Béné, M C, Duetz, C, Matarraz, S, Oelschlaegel, U, Westers, T M, Wagner-Ballon, O, Kordasti, S, Valent, P, Preijers, F, Alhan, C, Bellos, F, Bettelheim, P, Burbury, K, Chapuis, N, Cremers, E, Della Porta, M G, Dunlop, A, Eidenschink-Brodersen, L, Font, P, Fontenay, M, Hobo, W, Ireland, R, Johansson, U, Loken, M R, Ogata, K, Orfao, A, Psarra, K, Saft, L, Subira, D, te Marvelde, J, Wells, D A, van der Velden, V H J, Kern, W & van de Loosdrecht, A A 2023, ' Multiparameter flow cytometry in the evaluation of myelodysplasia : Analytical issues: Recommendations from the European LeukemiaNet/International Myelodysplastic Syndrome Flow Cytometry Working Group ', Cytometry Part B-Clinical Cytometry, vol. 104, no. 1, pp. 27-50 . https://doi.org/10.1002/cyto.b.22108
Contains fulltext : 290820.pdf (Publisher’s version ) (Open Access) Multiparameter flow cytometry (MFC) is one of the essential ancillary methods in bone marrow (BM) investigation of patients with cytopenia and suspected myelodysplastic syndrome (M
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::49ad55dec7b7811b97d7a4dba75e8123
http://www.scopus.com/inward/record.url?scp=85144283609&partnerID=8YFLogxK
Zobrazit plný text záznamu
4
Flow cytometric analysis of myelodysplasia: Pre-analytical and technical issues—Recommendations from the European LeukemiaNet
Autor: Vincent H. J. van der Velden, Frank Preijers, Ulrika Johansson, Theresia M. Westers, Alan Dunlop, Anna Porwit, Marie C. Béné, Peter Valent, Jeroen te Marvelde, Orianne Wagner‐Ballon, Uta Oelschlaegel, Leonie Saft, Sharham Kordasti, Robin Ireland, Eline Cremers, Canan Alhan, Carolien Duetz, Willemijn Hobo, Nicolas Chapuis, Michaela Fontenay, Peter Bettelheim, Lisa Eidenshink‐Brodersen, Patricia Font, Michael R. Loken, Sergio Matarraz, Kiyoyuki Ogata, Alberto Orfao, Katherina Psarra, Dolores Subirá, Denise A. Wells, Matteo G. Della Porta, Kate Burbury, Frauke Bellos, Elisabeth Weiß, Wolfgang Kern, Arjan van de Loosdrecht
Publikováno v: Cytometry Part B-Clinical Cytometry, 104(1), 15-26. Wiley-Liss Inc.
Cytometry Part B: Clinical Cytometry
Cytometry Part B: Clinical Cytometry, 2021, Online ahead of print. ⟨10.1002/cyto.b.22046⟩
van der Velden, V H J, Preijers, F, Johansson, U, Westers, T M, Dunlop, A, Porwit, A, Béné, M C, Valent, P, te Marvelde, J, Wagner-Ballon, O, Oelschlaegel, U, Saft, L, Kordasti, S, Ireland, R, Cremers, E, Alhan, C, Duetz, C, Hobo, W, Chapuis, N, Fontenay, M, Bettelheim, P, Eidenshink-Brodersen, L, Font, P, Loken, M R, Matarraz, S, Ogata, K, Orfao, A, Psarra, K, Subirá, D, Wells, D A, Della Porta, M G, Burbury, K, Bellos, F, Weiß, E, Kern, W & van de Loosdrecht, A 2023, ' Flow cytometric analysis of myelodysplasia : Pre-analytical and technical issues—Recommendations from the European LeukemiaNet ', Cytometry Part B-Clinical Cytometry, vol. 104, no. 1, pp. 15-26 . https://doi.org/10.1002/cyto.b.22046
Cytometry Part B-clinical Cytometry, 104(1), 15-26. Wiley-Liss Inc.
Cytometry. Part B-Clinical Cytometry, 104, 15-26
Cytometry. Part B-Clinical Cytometry, 104, 1, pp. 15-26
Contains fulltext : 290818.pdf (Publisher’s version ) (Open Access) BACKGROUND: Flow cytometry (FCM) aids the diagnosis and prognostic stratification of patients with suspected or confirmed myelodysplastic syndrome (MDS). Over the past few years, s
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::cc77f524a1e2dc51e2deefdc85b2033d
https://research.vumc.nl/en/publications/fa9d1b63-ecd0-4b72-9539-919bf4bd4bff
Zobrazit plný text záznamu
5
Akademický článek
Implementation of erythroid lineage analysis by flow cytometry in diagnostic models for myelodysplastic syndromes
Autor: Eline M.P. Cremers, Theresia M. Westers, Canan Alhan, Claudia Cali, Heleen A. Visser-Wisselaar, Dana A. Chitu, Vincent H.J. van der Velden, Jeroen G. te Marvelde, Saskia K. Klein, Petra Muus, Edo Vellenga, Georgina E. de Greef, Marie-Cecile C.J.C. Legdeur, Pierre W. Wijermans, Marian J.P.L. Stevens-Kroef, Pedro da Silva-Coelho, Joop H. Jansen, Gert J. Ossenkoppele, Arjan A. van de Loosdrecht
Publikováno v: Haematologica, Vol 102, Iss 2 (2017)
Flow cytometric analysis is a recommended tool in the diagnosis of myelodysplastic syndromes. Current flow cytometric approaches evaluate the (im)mature myelo-/monocytic lineage with a median sensitivity and specificity of ~71% and ~93%, respectively
Externí odkaz: https://doaj.org/article/ce60285c497d4c0a8b8092e8a4f0c35f
Zobrazit plný text záznamu
6
Distinct bone marrow immunophenotypic features define the splicing factor 3B subunit 1 (SF3B1)-mutant myelodysplastic syndromes subtype
Autor: Canan Alhan, Arjan A. van de Loosdrecht, Dana A. Chitu, Aniek O. de Graaf, Heleen Visser-Wisselaar, Bianca Venniker-Punt, Linda Smit, Eline M. P. Cremers, Theresia M. Westers, Florentien E. M. in ’t Hout, Joop H. Jansen, Carolien Duetz
Publikováno v: British Journal of Haematology, 193(4), 798-803. Wiley-Blackwell
British Journal of Haematology
British Journal of Haematology, 193(4), 798-803. Wiley
Duetz, C, Westers, T M, in ’t Hout, F E M, Cremers, E M P, Alhan, C, Venniker-Punt, B, Visser-Wisselaar, H A, Chitu, D A, de Graaf, A O, Smit, L, Jansen, J H & van de Loosdrecht, A A 2021, ' Distinct bone marrow immunophenotypic features define the splicing factor 3B subunit 1 (SF3B1)-mutant myelodysplastic syndromes subtype ', British Journal of Haematology, vol. 193, no. 4, pp. 798-803 . https://doi.org/10.1111/bjh.17414
British Journal of Haematology, 193, 4, pp. 798-803
British Journal of Haematology, 193, 798-803
Summary Splicing factor 3B subunit 1 (SF3B1) mutations define a distinct myelodysplastic syndromes (MDS) patient group with a relatively favourable disease course and high response rates to luspatercept. Few data are available on bone marrow phenotyp
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::5eebe7d770aa11c7b41867afabcdf9c0
https://doi.org/10.1111/bjh.17414
Zobrazit plný text záznamu
7
Monitoring treatment with 5-Azacitidine by flow cytometry predicts duration of hematological response in patients with myelodysplastic syndrome
Autor: Uta Oelschlaegel, Theresia M. Westers, Lennart Nilsson, Anna Porwit, Arjan A. van de Loosdrecht, Dolores Subirá, Katherina Psarra, N. Golbano, Dunia de Miguel, Canan Alhan
Publikováno v: Annals of Hematology, 100(7), 1711-1722. Springer Verlag
Subirá, D, Alhan, C, Oelschlaegel, U, Porwit, A, Psarra, K, Westers, T M, Golbano, N, Nilsson, L, van de Loosdrecht, A A & de Miguel, D 2021, ' Monitoring treatment with 5-Azacitidine by flow cytometry predicts duration of hematological response in patients with myelodysplastic syndrome ', Annals of Hematology, vol. 100, no. 7, pp. 1711-1722 . https://doi.org/10.1007/s00277-021-04411-4
5-Azacitidine (AZA) therapy is used in high-risk myelodysplastic syndrome (MDS) patients who often show abnormalities in their immunophenotype. We explored the potential impact of AZA on these immunophenotypic abnormalities in serial bone marrow stud
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::0c89965ab590f567eb36eb21596af8d5
https://research.vumc.nl/en/publications/5abbe889-2c12-41bf-a8e2-5812a20f2b9b
Zobrazit plný text záznamu
8
Dysplasia and PNH-type cells in bone marrow aspirates of myelodysplastic syndromes
Autor: Dana A. Chitu, Canan Alhan, Arjan A. van de Loosdrecht, Heleen Visser-Wisselaar, Theresia M. Westers
Publikováno v: Westers, T M, Alhan, C, Visser-Wisselaar, H A, Chitu, D A & van de Loosdrecht, A A 2021, ' Dysplasia and PNH-type cells in bone marrow aspirates of myelodysplastic syndromes ', Cytometry Part B-Clinical Cytometry . https://doi.org/10.1002/cyto.b.22038
Cytometry Part B-Clinical Cytometry, 104(2), 162-172. Wiley-Liss Inc.
Cytometry Part B-Clinical Cytometry. Wiley-Liss Inc.
Background: Flow cytometry is increasingly applied in cytopenic patients suspected for myelodysplastic syndromes (MDS). Analysis includes evaluation of antigen expression patterns in granulocytes of which, for example, partial lack of CD16 may indica
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::582eacc791d99baed6e7e15042ede096
https://research.vumc.nl/en/publications/5d6fca22-6184-4431-bd38-0cc645addda3
Zobrazit plný text záznamu
9
Machine Learning-Based Flow Cytometry Diagnostics in Myelodysplastic Syndromes: Validation in the HOVON89 Clinical Trial (EudraCT 2008-002195-10)
Autor: Theresia M. Westers, Joop H. Jansen, Canan Alhan, Costa Bachas, Arjan A. van de Loosdrecht, Sofie Van Gassen, Yvan Saeys, Carolien Duetz, Eline M. P. Cremers, Margot F. van Spronsen, Aniek O. de Graaf, Florentien E. M. in ’t Hout, Dana A. Chitu, Heleen Visser-Wisselaar
Publikováno v: Blood, 136. American Society of Hematology
Duetz, C, Van Gassen, S, Westers, T M, in 't Hout, F, Cremers, E, Alhan, C, Bachas, C, Van Spronsen, M F, Visser-Wisselaar, H, Chitu, D, De Graaf, A O, Jansen, J, Saeys, Y & van de Loosdrecht, A 2020, ' Machine Learning-Based Flow Cytometry Diagnostics in Myelodysplastic Syndromes: Validation in the HOVON89 Clinical Trial (EudraCT 2008-002195-10) ', Blood, vol. 136 . https://doi.org/10.1182/blood-2020-136719
Introduction Flow cytometry is a recommended tool in the diagnostic work-up of cytopenic patients suspected for myelodysplastic syndromes. Currently used flow cytometry scores rely on human assessment of dysplastic features in the bone marrow. Althou
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::9b733e1e6d642fa9160cd22ab22cf568
https://research.vumc.nl/en/publications/258b89fd-5538-42b7-941a-639363db9f3b
Zobrazit plný text záznamu
10
Akademický článek
Multicenter validation of a reproducible flow cytometric score for the diagnosis of low-grade myelodysplastic syndromes: results of a European LeukemiaNET study
Autor: Matteo G. Della Porta, Cristina Picone, Cristiana Pascutto, Luca Malcovati, Hideto Tamura, Hiroshi Handa, Magdalena Czader, Sylvie Freeman, Paresh Vyas, Anna Porwit, Leonie Saft, Theresia M. Westers, Canan Alhan, Claudia Cali, Arjan A. van de Loosdrecht, Kiyoyuki Ogata
Publikováno v: Haematologica, Vol 97, Iss 8 (2012)
Background The current World Health Organization classification of myelodysplastic syndromes is based morphological evaluation of bone marrow dysplasia. In clinical practice, the reproducibility of the recognition of dysplasia is usually poor especia
Externí odkaz: https://doaj.org/article/20ee582402cc4feabe7c0712214443dd
Zobrazit plný text záznamu

Vyhledávací nástroje:

Upřesnit hledání

Omezení vyhledávání
Plný text Recenzováno Digitální knihovna AV ČR
Zdroje